Inventor · disambiguated record
Adrien Weingärtner
Also filed as: WEINGARTNER ADRIEN · WEINGÄRTNER ADRIEN
9 granted patents·7 pending applications·29 citations·filing 2018–2024
83Inventor score
Files withSILENCE THERAPEUTICS GMBH16
Top patents by PatentIndex Score
16 records- 0192US11499153B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2021·Granted Nov 15, 2022·2 cites·28 claims
- 0292US11319537B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2018·Granted May 3, 2022·18 cites·15 claims
- 0390US11174483B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Nov 16, 2021·6 cites·19 claims
- 0488US12054717B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 0582US11414660B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Aug 16, 2022·2 cites·20 claims
- 0680US2024327843A1Nucleic acids for inhibiting expression of lpa in a cellSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0776US2024200071A1Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkagesSILENCE THERAPEUTICS GMBH·Filed 2023·Application pending·0 cites
- 0868US11987794B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 0968US11753642B2Nucleic acids for inhibiting expression of C3 in a cellSILENCE THERAPEUTICS GMBH·Filed 2022·Granted Sep 12, 2023·0 cites·29 claims
- 1064US2023272385A1siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRANDSILENCE THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1162US2022025377A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 1261US11873489B2Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkagesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Jan 16, 2024·0 cites·14 claims
- 1357US2022195436A1Nucleic acids for inhibiting expression of c3 in a cellSILENCE THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1450US11560563B2SiRNAs with vinylphosphonate at the 5′ end of the antisense strandSILENCE THERAPEUTICS GMBH·Filed 2019·Granted Jan 24, 2023·0 cites·16 claims
- 1548US2021155926A1siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDSSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1647US2022017899A1Nucleic acids for inhibiting expression of c3 in a cellSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →